Novavax, Inc. (NVAX) to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11/12/2012 7:43:37 AM
ROCKVILLE, Md., Nov. 12, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on November 14, 2012 at 9:30am in New York City at the Pierre Hotel. A live webcast link for the presentation can be accessed via the Company website at www.novavax.com under Investor Info/Events.
comments powered by